GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker

Cited by papers we hold 7

• Modulating Glycolysis to Improve Cancer Therapy · 2023
  No notice
• Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy · 2021
  No notice
• Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality · 2019
  No notice
• Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy · 2019
  No notice
• Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876 · 2018
  No notice
• Glycosylation, an effective synthetic strategy to improve the bioavailability of therapeutic peptides · 2016
  No notice
• Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer · 2015
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.